Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

✍ Scribed by G. Specchia; D. Pastore; P. Carluccio; G. Spinosa; M. Giannoccaro; R. Rizzi; A. Mestice; V. Liso

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 95 KB
• Volume: 86
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-007-0272-z